AveXis (AVXS) Drops to Session Lows; Report Sees Stock Due for 'Substantial' Correction

August 31, 2016 3:13 PM EDT
Get Alerts AVXS Hot Sheet
Trade AVXS Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

(Updated - August 31, 2016 3:16 PM EDT)

AveXis (NASDAQ: AVXS) drops to session lows.

UPDATE - The drop could be due to a negative Biotech, Beats & BBQ report, which offered the following summary of findings:

We believe, for a number of key reasons...that AVXS is significantly overvalued relative to its accomplishments and commercialization prospects. It is our belief that the stock is due for a substantial correction as its pathway to market become dimmer by the day and its ability to generate solid, placebo controlled clinical data become non-existent.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Short Sales, Trader Talk

Add Your Comment